Cargando…

Integrated single-cell and transcriptome sequencing analyses determines a chromatin regulator-based signature for evaluating prognosis in lung adenocarcinoma

BACKGROUND: Accumulating evidence has highlighted the significance of chromatin regulator (CR) in pathogenesis and progression of cancer. However, the prognostic role of CRs in LUAD remains obscure. We aim to detect the prognostic value of CRs in LUAD and create favorable signature for assessing pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Qingtong, Han, Song, Liu, Xiong, Wang, Saijian, Ma, Haitao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618736/ https://www.ncbi.nlm.nih.gov/pubmed/36324565 http://dx.doi.org/10.3389/fonc.2022.1031728

Ejemplares similares

Integrated analysis of single-cell and Bulk RNA sequencing reveals a malignancy-related signature in lung adenocarcinoma
por: Wu, Mengxi, et al.
Publicado: (2023)

Determination of a DNA repair-related gene signature with potential implications for prognosis and therapeutic response in pancreatic adenocarcinoma
por: Lai, Jinzhi, et al.
Publicado: (2022)

Establishment of lactate-metabolism-related signature to predict prognosis and immunotherapy response in patients with colon adenocarcinoma
por: Zou, Zhengrong, et al.
Publicado: (2022)

Integrated Analysis of Cell Cycle–Related and Immunity-Related Biomarker Signatures to Improve the Prognosis Prediction of Lung Adenocarcinoma
por: Chen, Fangyu, et al.
Publicado: (2021)

Pyroptosis-Related LncRNA Signatures Correlate With Lung Adenocarcinoma Prognosis
por: Huang, Hua, et al.
Publicado: (2022)

A New RBPs-Related Signature Predicts the Prognosis of Colon Adenocarcinoma Patients
por: Chang, Kaili, et al.
Publicado: (2021)

Identification of an Immune-Related Signature for Predicting Prognosis in Patients With Pancreatic Ductal Adenocarcinoma
por: Wang, Weijia, et al.
Publicado: (2021)

The immune escape signature predicts the prognosis and immunotherapy sensitivity for pancreatic ductal adenocarcinoma
por: Lu, Hao, et al.
Publicado: (2022)

Glycosyltransferase-related long non-coding RNA signature predicts the prognosis of colon adenocarcinoma
por: Zhang, Jiawei, et al.
Publicado: (2022)

A novel glycosyltransferase-related lncRNA signature correlates with lung adenocarcinoma prognosis
por: Bian, Chengyu, et al.
Publicado: (2022)

A novel defined cuproptosis-related gene signature for predicting the prognosis of colon adenocarcinoma
por: Luo, Bixian, et al.
Publicado: (2022)

Identification of an unfolded protein response-related signature for predicting the prognosis of pancreatic ductal adenocarcinoma
por: Fang, Lishan, et al.
Publicado: (2023)

Cuproptosis-related signature predicts prognosis, immunotherapy efficacy, and chemotherapy sensitivity in lung adenocarcinoma
por: Wu, Gujie, et al.
Publicado: (2023)

Tumor subtypes and signature model construction based on chromatin regulators for better prediction of prognosis in uveal melanoma
por: Li, Yue, et al.
Publicado: (2023)

Tumor-Infiltrating Immune Cell Signature Predicts the Prognosis and Chemosensitivity of Patients With Pancreatic Ductal Adenocarcinoma
por: Gao, Yuzhen, et al.
Publicado: (2020)

Prognostic signature of lipid metabolism associated LncRNAs predict prognosis and treatment of lung adenocarcinoma
por: Zhao, Jie, et al.
Publicado: (2022)

Identification and validation of a novel angiogenesis-related gene signature for predicting prognosis in gastric adenocarcinoma
por: Xu, Peipei, et al.
Publicado: (2023)

Integrative Proteo-Genomic Analysis for Recurrent Survival Prognosis in Colon Adenocarcinoma
por: Ai, FeiYan, et al.
Publicado: (2022)

Identification and validation of a novel signature based on cell-cell communication in head and neck squamous cell carcinoma by integrated analysis of single-cell transcriptome and bulk RNA-sequencing
por: Wang, Jian, et al.
Publicado: (2023)

Identification of a Ferroptosis-Related LncRNA Signature as a Novel Prognosis Model for Lung Adenocarcinoma
por: Lu, Lu, et al.
Publicado: (2021)

A Novel Pyroptosis-Related Gene Signature for Predicting the Prognosis and the Associated Immune Infiltration in Colon Adenocarcinoma
por: Chen, Zhiyuan, et al.
Publicado: (2022)

Cuproptosis-related lncRNA signatures: Predicting prognosis and evaluating the tumor immune microenvironment in lung adenocarcinoma
por: Zhang, Pengpeng, et al.
Publicado: (2023)

Integrated Transcriptome and Pathway Analyses Revealed Multiple Activated Pathways in Breast Cancer
por: Vishnubalaji, Radhakrishnan, et al.
Publicado: (2019)

Integrative Analysis of Identifying Methylation-Driven Genes Signature Predicts Prognosis in Colorectal Carcinoma
por: Huang, Hao, et al.
Publicado: (2021)

Integrated analysis of the M2 macrophage-related signature associated with prognosis in ovarian cancer
por: Peng, Caijiao, et al.
Publicado: (2022)

Characterization of chromatin regulators identified prognosis and heterogeneity in hepatocellular carcinoma
por: Dai, Yin-wei, et al.
Publicado: (2022)

Comprehensive analyses reveal the prognosis and biological function roles of chromatin regulators in lung adenocarcinoma
por: Yang, Baishuang, et al.
Publicado: (2023)

An 11-Gene Signature Risk-Prediction Model Based on Prognosis-Related miRNAs and Their Target Genes in Lung Adenocarcinoma
por: Zhou, Ning, et al.
Publicado: (2021)

The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma
por: Liu, Cong, et al.
Publicado: (2022)

An Integrated Three-Long Non-coding RNA Signature Predicts Prognosis in Colorectal Cancer Patients
por: Liu, Yuhang, et al.
Publicado: (2019)

Integrative dissection of 5-hydroxytryptamine receptors-related signature in the prognosis and immune microenvironment of breast cancer
por: Zhan, Dandan, et al.
Publicado: (2023)

Transcriptomic Analyses of the Adenoma-Carcinoma Sequence Identify Hallmarks Associated With the Onset of Colorectal Cancer
por: Hong, Qin, et al.
Publicado: (2021)

Changes in the Transcriptome and Chromatin Landscape in BRAFi-Resistant Melanoma Cells
por: Reddi, Kiran Kumar, et al.
Publicado: (2022)

Integrated Multiomics Analyses Revealing Different Molecular Profiles Between Early- and Late-Stage Lung Adenocarcinoma
por: Yue, Dongsheng, et al.
Publicado: (2021)

Integrated Single-Cell and Transcriptome Sequencing Analyses Identify Dipeptidase 2 as an Immune-Associated Prognostic Biomarker for Lung Adenocarcinoma
por: Zhang, Xiangqian, et al.
Publicado: (2023)

Identification of a Gene Signature Closely Related to Immunosuppressive Tumour Microenvironment Predicting Prognosis of Patients in EGFR Mutant Lung Adenocarcinoma
por: Li, Jia, et al.
Publicado: (2021)

Transcriptional, chromatin, and metabolic landscapes of LDHA inhibitor–resistant pancreatic ductal adenocarcinoma
por: Malvi, Parmanand, et al.
Publicado: (2022)

The integrated single-cell analysis developed an immunogenic cell death signature to predict lung adenocarcinoma prognosis and immunotherapy
por: Zhang, Pengpeng, et al.
Publicado: (2023)

Dissecting the single-cell transcriptome network of macrophage and identifies a signature to predict prognosis in lung adenocarcinoma
por: Hu, Zhengyang, et al.
Publicado: (2023)

Necroptosis-related lncRNAs: Combination of bulk and single-cell sequencing reveals immune landscape alteration and a novel prognosis stratification approach in lung adenocarcinoma
por: Yao, Yizhu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7f2k8p578gh67r5a514khuf6ao